drugset / Trial / NCT00539825
Effect of GSK704838 In Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
GSK704838C is a potent, pan-active mAChR antagonist, which is being developed for once-daily treatment of chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2007-09
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK704838 | Unknown | — | Inhaled |